Get the Stockscreener App
2.70
1.89%
0.05
After Hours:
2.70
Entero Therapeutics Inc stock is traded at $2.70, with a volume of 16,279.
It is up +1.89% in the last 24 hours and up +118.02% over the past month.
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
See More
Previous Close:
$2.65
Open:
$2.65
24h Volume:
16,279
Relative Volume:
0.01
Market Cap:
$4.21M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+18.68%
1M Performance:
+118.02%
6M Performance:
+59.35%
1Y Performance:
+122.61%
1-Day Range:
$2.59
$2.71
1-Week Range:
$2.05
$2.9499
52-Week Range:
$0.84
$2.9499
Entero Therapeutics Inc Stock (ENTO) Company Profile
Name
Entero Therapeutics Inc
Sector
Industry
Phone
561-589-7020
Address
777 YAMATO ROAD, BOCA RATON
Compare ENTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
2.70 | 4.21M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Entero Therapeutics Inc Stock (ENTO) Latest News
Identifying reversal signals in Entero Therapeutics Inc.2025 Short Interest & Stock Market Timing Techniques - Newser
Entero Therapeutics Inc. stock momentum explainedGold Moves & Fast Exit Strategy with Risk Control - Newser
Can Entero Therapeutics Inc. recover in the next quarterWeekly Trade Analysis & Reliable Trade Execution Plans - Newser
Ranking Entero Therapeutics Inc. among high performing stocks via toolsWeekly Investment Summary & High Conviction Buy Zone Alerts - Newser
Aug Retail: How does Entero Therapeutics Inc. score in quality rankings2025 Volume Leaders & Technical Buy Zone Confirmation - خودرو بانک
Is Entero Therapeutics Inc. stock reversal real or fakeWeekly Investment Report & Verified Swing Trading Watchlist - Newser
How to build a custom watchlist for Entero Therapeutics Inc.Quarterly Trade Review & Capital Efficient Trade Techniques - Newser
Combining price and volume data for Entero Therapeutics Inc.Portfolio Gains Summary & Daily Growth Stock Investment Tips - Newser
Price action breakdown for Entero Therapeutics Inc.Earnings Growth Summary & Safe Capital Growth Plans - Newser
Visual analytics tools that track Entero Therapeutics Inc. performanceJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Should you wait for a breakout in Entero Therapeutics Inc.Trade Entry Report & Accurate Technical Buy Alerts - Newser
News impact scoring models applied to Entero Therapeutics Inc.Volume Spike & Weekly Watchlist for Hot Stocks - Newser
Detecting support and resistance levels for Entero Therapeutics Inc.Gap Up & Fast Entry Momentum Trade Alerts - Newser
Is now a turning point for Entero Therapeutics Inc.July 2025 Chart Watch & Fast Entry High Yield Stock Tips - Newser
Does Entero Therapeutics Inc. qualify in momentum factor screeningPortfolio Return Report & Technical Entry and Exit Tips - Newser
Entero Therapeutics Inc. stock volume spike explainedSell Signal & Technical Analysis for Trade Confirmation - Newser
What are the future prospects of Entero Therapeutics Inc.Trade Performance Summary & Safe Entry Point Alerts - khodrobank.com
How to build a dashboard for Entero Therapeutics Inc. stockJuly 2025 Big Picture & Step-by-Step Swing Trade Plans - Newser
Key resistance and support levels for Entero Therapeutics Inc.Market Activity Recap & Precise Entry and Exit Recommendations - Newser
How to read the order book for Entero Therapeutics Inc.Market Risk Report & Fast Gain Stock Trading Tips - Newser
Quantitative breakdown of Entero Therapeutics Inc. recent moveWeekly Market Report & Weekly High Conviction Trade Ideas - Newser
Value Recap: Can Entero Therapeutics Inc. stock double in the next yearJuly 2025 WrapUp & Smart Allocation Stock Tips - خودرو بانک
Is it too late to sell Entero Therapeutics Inc.IPO Watch & Trade Opportunity Analysis - Newser
Can Entero Therapeutics Inc. maintain sales growth2025 Historical Comparison & Daily Profit Maximizing Trade Tips - خودرو بانک
Should I hold or sell Entero Therapeutics Inc. now2025 Top Decliners & Risk Controlled Daily Trade Plans - خودرو بانک
Will Entero Therapeutics Inc. price bounce be sustainableQuarterly Profit Review & Weekly Breakout Stock Alerts - Newser
Can Entero Therapeutics Inc. lead its sector in growth2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
Pattern recognition hints at Entero Therapeutics Inc. upsideMarket Performance Summary & Daily Entry Point Alerts - Newser
Evaluating Entero Therapeutics Inc. with trendline analysisJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - Newser
Can Entero Therapeutics Inc. stock double in the next year2025 AllTime Highs & Daily Stock Trend Reports - خودرو بانک
Will Entero Therapeutics Inc. outperform during market ralliesMarket Sentiment Review & AI Driven Stock Price Forecasts - خودرو بانک
Strategies to average down on Entero Therapeutics Inc.July 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Is Entero Therapeutics Inc. stock technically oversoldJuly 2025 Selloffs & Safe Entry Point Alerts - خودرو بانک
Is now the right time to enter Entero Therapeutics Inc.July 2025 Selloffs & Capital Protection Trade Alerts - خودرو بانک
How does Entero Therapeutics Inc. score in quality rankingsMarket Sentiment Report & Technical Pattern Based Buy Signals - خودرو بانک
Custom strategy builders for tracking Entero Therapeutics Inc.Index Update & Consistent Growth Equity Picks - Newser
Is Entero Therapeutics Inc. meeting your algorithmic filter criteriaMarket Weekly Review & Low Volatility Stock Suggestions - Newser
Entero Therapeutics Inc Stock (ENTO) Financials Data
There is no financial data for Entero Therapeutics Inc (ENTO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):